Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

Crest Ventures Ltd

CREST
Finance & Investments - Others

Crest Ventures Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

The sharpest disagreement: the price moved −5.8% in a year while annual EPS moved −47.1% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is in a confirmed uptrend (8 weeks in) while the P/BV sits at the 40th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −57.7% year on year, with the the net margin at 36.7%. What settles it: whether earnings grow into a price that has already moved.

Stage
Deteriorating
partial read
Price
₹355
−5.8% 1Y
P/BV
0.8×
40th pctile
of its own 11-year range
Revenue (Jun 26)
₹30.0 Cr
−52.4% YoY
Profit (Jun 26)
₹11.0 Cr
−57.7% YoY
Net margin
36.7%
−4.6 pp YoY
ROE
4%
FY26
ROA
3.19%
latest
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified. PEG is the exception: the quarterly curve is not drawn at all. PEG asks what is being paid for growth — both sides of that division come from the source that could not be checked, so it is withheld instead of marked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Crest Ventures Ltd trades at ₹355, in a confirmed uptrend and 8 weeks into that stage. That is −3.5% against its own 200-day average. It sits at 49% of a 52-week range of ₹310 to ₹402. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (7 weeks and counting).

Today the stock is in a confirmed uptrend — week 8 of stage 2. At ₹355 it trades −3.5% versus its 200-day average and sits at 49% of its 52-week range (₹310–₹402).

Sep 26: ₹355 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−3.5% versus the 200-day line, week 8 of stage 2
Price50-day avg200-day avg
S2S4₹619₹507₹395₹283₹171₹355₹368Sep 23Jun 24Mar 25Jan 26Sep 26
S2S4₹619₹507₹395₹283₹171₹355₹368Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (555 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +989% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.

Crest Ventures Ltd trades at 0.8× P/BV, mid-range by its own standards (40th percentile). Its long-run median P/BV is 0.8×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/BV of 0.8× is mid-range by its own standards (40th percentile), against a long-run median of 0.8× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

The honest context for that discount: a bank earning about 4% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.

P/BV 0.8× vs a 0.8× long-run median P/BV, weekly (left axis); book value per share, weekly (right axis). 10.5-year window; brief peaks above 1.7× shown pinned at the top. The book value / share bars are red where the reading is lower than the quarter before.
mid-range by its own standards (40th percentile)
P/BVMedianBook value / share (quarterly)
1.8×₹4801.4×₹3601.0×₹2400.6×₹1200.2×₹0.0×0.80×₹444Mar 16Nov 18Jun 21Feb 24Sep 26
1.8×₹4801.4×₹3601.0×₹2400.6×₹1200.2×₹0.0×0.80×₹444Mar 16Jun 21Sep 26
P/BV
0.8×
40th percentile of 11y

🚨 Why the multiple sits where it does: over the past year book value grew while the price moved −5.8% — price and book moved together, holding the multiple in its range.

The price move, decomposed: over 5y, of the +23.9%/yr price move, ~+17.0%/yr came from book-value growth and ~+6.9 pp from the multiple (expanding); over 10y, of the +17.5%/yr price move, ~+16.0%/yr came from book-value growth and ~+1.5 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

03 · What the price assumes

What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.

Solved at its 13 June 2026 price, Crest Ventures Ltd was paying for profit growth of about 16.1% a year. Profit itself has compounded 2.6% a year over the past 10 years. Today the market pays 0.8× P/BV, the 40th percentile of its own 11-year range.

What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is far above what this company has actually delivered.

How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.

04 · Stage: Deteriorating

Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Crest Ventures Ltd reads as deteriorating on its fundamental arc. Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −33.2% latest against +36.7% at its 12-quarter best), ROE slipping at 4.0%. The read is built from 8 quarters across 4 curves, on partial evidence.

Growth, year by year: revenue −22.1% in FY26, profit −46.7% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
1,131%331%808%217%485%103%162%−11%−161%−125%%%−22.1%−46.7%FY16FY21FY26
1,131%331%808%217%485%103%162%−11%−161%−125%%%−22.1%−46.7%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over, profit rolling over
RevenueProfitEPS
42%64%22%33%1.8%2.6%−19%−28%−39%−58%%%−33.2%−49.3%−48.8%Sep 23Dec 24Jun 26
42%64%22%33%1.8%2.6%−19%−28%−39%−58%%%−33.2%−49.3%−48.8%Sep 23Dec 24Jun 26
ROE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROE
54%40%27%14%0.0%%4%FY23FY24FY26
54%40%27%14%0.0%%4%FY23FY24FY26
Revenue growth
Falling
latest −33.2% · span −33.2% to +36.7%
Profit growth
Flat
latest −49.3% · span −49.5% to +55.3%
EPS growth
Flat
latest −48.8% · span −50.0% to +51.9%
ROE
Falling
latest 4.0% · span 4.0%–50.0%

🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−22.1%−37.5%+23.7%+12.5%
Profit−46.7%−50.5%+74.1%+2.6%
EPS−47.1%−50.9%+73.4%+1.5%
Share price−5.8%+13.7%+23.9%+17.5%
Revenue YoY (Jun 26)
−52.4%
latest quarter vs a year ago
Profit YoY (Jun 26)
−57.7%
latest quarter vs a year ago
Revenue 10y
12.5%
long-run compound pace
05 · 4-Factor Sector Score

4-Factor Sector Score

33.0/100 — rank 28 of 34 in Finance & Investments - Others · 86% evidence confidence

Crest Ventures Ltd scores 33.0 out of 100 against the 34 companies it is compared with in Finance & Investments - Others, ranking 28. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 7.1 + 12.4 + 8 + 5.5 = 33. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.

06 · Revenue

Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.

Crest Ventures Ltd reported ₹30.0 Cr of income in the Jun 26 quarter, −52.4% year on year. Over 10 years it has compounded at 12.5% a year. The last full year, FY26, came in at ₹159 Cr. The last four reported quarters add to ₹127 Cr.

FY26 revenue came in at ₹159 Cr (−22.1% on the year), capping 10 years at 12.5% compound. The latest quarter (Jun 26) printed ₹30.0 Cr, −52.4% year on year.

FY26 revenue ₹159 Cr (−22.1% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
12.5% a year over 10 years
RevenueYoY growth
7031,131%527808%352485%176162%0−161%₹ Cr%₹159−22.1%FY16FY21FY26
7031,131%527808%352485%176162%0−161%₹ Cr%₹159−22.1%FY16FY21FY26
Jun 26: ₹30.0 Cr (−52.4% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
83164%62106%4248%21−10%0−68%₹ Cr%₹30−52.4%Sep 23Dec 24Jun 26
83164%62106%4248%21−10%0−68%₹ Cr%₹30−52.4%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged −30.1% growth against the decade's 12.5% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −33.2% over the last 4 quarters against −25.7%/yr over the last 8 — rolling over; TTM profit −49.3% vs −43.4%/yr — rolling over.

07 · Net margin

Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.

Crest Ventures Ltd's net margin is 36.7% in the Jun 26 quarter, −4.6 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 5.5% to 99.0%. The current quarter sits inside that band.

The latest quarter's net margin is 36.7%, −4.6 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 5.5%–99.0%.

Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.

FY26: 30.2% Net margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 5.5–99.0% band over 13 years
net marginYoY change (pp)
106%72%79%36%52%0.0%25%−36%−2.0%−72%%%30.2%−13.9%FY14FY20FY26
106%72%79%36%52%0.0%25%−36%−2.0%−72%%%30.2%−13.9%FY14FY20FY26
Jun 26: 36.7% net margin (−4.6 pp YoY) Quarterly net margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Net profit as a share of total revenue, per quarter.
Net marginYoY change (pp)
69%52%54%28%39%3.7%24%−21%9.2%−45%%%36.7%−4.6%Sep 23Dec 24Jun 26
69%52%54%28%39%3.7%24%−21%9.2%−45%%%36.7%−4.6%Sep 23Dec 24Jun 26
08 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Crest Ventures Ltd earned ₹11.0 Cr of net profit in the Jun 26 quarter, −57.7% year on year. Full-year FY26 profit was ₹48.0 Cr. The 10-year compound rate is 2.6%. That is 36.7% of the quarter's revenue. The same quarter a year earlier earned ₹26.0 Cr.

Jun 26 profit was ₹11.0 Cr, −57.7% year on year. On the full year, FY26 printed ₹48.0 Cr (−46.7%), and the 10-year compound rate is 2.6%.

FY26 profit ₹48.0 Cr (−46.7% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
2.6% a year over 10 years
Net profitYoY growth
4283,463%3212,508%2141,553%107598%0−357%₹ Cr%₹48−46.7%FY16FY21FY26
4283,463%3212,508%2141,553%107598%0−357%₹ Cr%₹48−46.7%FY16FY21FY26
Jun 26: ₹11.0 Cr (−57.7% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
54798%41563%27328%1493%0−143%₹ Cr%₹11−57.7%Sep 23Dec 24Jun 26
54798%41563%27328%1493%0−143%₹ Cr%₹11−57.7%Sep 23Dec 24Jun 26

🚨 Why profit moved: revenue contributed −52.4% and the margin −4.6 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −39.1% vs revenue −30.1%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

09 · Asset quality — the ladder

Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.

Loan-book quality history is not available for Crest Ventures Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.

We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.

Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.

10 · The loan book

The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.

Crest Ventures Ltd's revenue grew −22.1% in FY26 to ₹159 Cr, so the book is flat. The latest quarter ran −52.4% year on year. The net margin on that income is 36.7%, −4.6 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.

FY26 revenue was ₹159 Cr, −22.1% on the year, and the latest quarter ran −52.4% year on year. The net margin on that revenue is 36.7% this quarter (−4.6 pp YoY) — growth with a narrowing margin on it.

FY26: revenue ₹159 Cr (−22.1% YoY) with the net margin at 30.2% Revenue by fiscal year, ₹ Cr (bars, left); net margin, % (line, right). 11-year window. A bar is red when it is lower than the year before.
RevenueNet margin
703106%52779%35252%17625%0−2.0%₹ Cr%₹15930.2%FY16FY18FY21FY23FY26
703106%52779%35252%17625%0−2.0%₹ Cr%₹15930.2%FY16FY21FY26

The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.

11 · Returns on equity and assets

Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.⚠ unverified

Crest Ventures Ltd earns a return on equity of 4% in FY26. Its trough over the ladder below was 1% in FY21. On the asset side every ₹100 of the balance sheet earned about ₹3.19, which is the return before leverage is applied.

FY26 ROE came in at 4%, recovered from a FY21 trough of 1%. On assets, the latest reading is about 3.19% — every ₹100 the bank deploys earns roughly ₹3.19 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.

FY26: ROE 4%, ROA 3.20% Return on equity by fiscal year, % (line, left); return on assets, % (line, right). 13-year window. A lender is judged on ROE and ROA — return on invested capital does not apply to a bank.
up from a FY21 trough of 1%
ROEROA
54%39%40%29%26%19%11%9.3%−2.9%−0.8%%%4%3.2%FY14FY20FY26
54%39%40%29%26%19%11%9.3%−2.9%−0.8%%%4%3.2%FY14FY20FY26
Q4 FY26: ROE 3.5% (TTM) Trailing-twelve-month return on equity (left), per quarter, %. Last 12 quarters, anchored to the annual figure.
ROE (TTM)
19%14%9.4%4.6%0.0%%3.5%Q1 FY24Q2 FY25Q4 FY26
19%14%9.4%4.6%0.0%%3.5%Q1 FY24Q2 FY25Q4 FY26

Why ROE moved: profit compounded 2.6% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.

12 · Debt

Debt

For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.

A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.

13 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of Crest Ventures Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.5 points over the same window, to 1.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: +0.7 points over 8 quarters to 69.8%; Foreign institutions: +0.5 points over 8 quarters to 1.7%.

Fiscal-year ends: promoters +0.6 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Public
75%55%36%16%−4.0%%69.8%1.7%27.9%Mar 24Mar 25Mar 26
75%55%36%16%−4.0%%69.8%1.7%27.9%Mar 24Mar 25Mar 26
A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Public
75%55%36%16%−4.2%%69.8%1.7%27.8%Jun 23Dec 24Jun 26
75%55%36%16%−4.2%%69.8%1.7%27.8%Jun 23Dec 24Jun 26
14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Crest Ventures Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.

The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.

15 · Related companies · Finance & Investments - Others
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Fedders Holding LtdFEDDERSHOL 74.7/100Favorable setup80% evidence BREAKING OUT 25.1/35 Income -6.4% · PAT 100% 81% evidence 18.3/25 ROA 10.9% · ROE 11.6% · GNPA — 68% evidence 12.8/20 P/BV 1.35× · P/BV÷ROE 0.12 70% evidence 18.5/20 RS sector 7.4% · RS bench 9.2% · 1Y 5.8%12 of 12 weeks ahead 100% evidence
Exact sum: 25.1 + 18.3 + 12.8 + 18.5 = 74.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Abans Financial Services LtdAFSL 70.5/100Favorable setup80% evidence TURNING 24.3/35 Income 100% · PAT 17.9% 81% evidence 14.5/25 ROA 3.6% · ROE 8.3% · GNPA — 68% evidence 17.0/20 P/BV 0.81× · P/BV÷ROE 0.1 100% evidence 14.7/20 RS sector 21% · RS bench 0.4% · 1Y -8.3%0 of 10 weeks ahead 70% evidence
Exact sum: 24.3 + 14.5 + 17 + 14.7 = 70.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Gretex Corporate Services LtdGCSL 63.8/100Mixed-positive evidence86% evidence LEADER 24.5/35 Income -19.4% · PAT 100% 81% evidence 18.5/25 ROA 11.5% · ROE 12.7% · GNPA — 68% evidence 1.6/20 P/BV 8.3× · P/BV÷ROE 0.65 100% evidence 19.2/20 RS sector 56.1% · RS bench 60.7% · 1Y 97.3%11 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 18.5 + 1.6 + 19.2 = 63.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
4Saraswati Commercial (India) LtdZSARACOM 63.2/100Mixed-positive evidence80% evidence BREAKING OUT 30.6/35 Income 100% · PAT 100% 81% evidence 15.2/25 ROA 7.6% · ROE 8.9% · GNPA — 68% evidence 11.6/20 P/BV 1.07× · P/BV÷ROE 0.12 100% evidence 5.8/20 RS sector -17% · RS bench -3.6% · 1Y -16.2%8 of 8 weeks ahead 70% evidence
Exact sum: 30.6 + 15.2 + 11.6 + 5.8 = 63.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17% and the one-year return is -16.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
5BF Investment LtdBFINVEST 60.1/100Mixed-positive evidence86% evidence FADING 27.3/35 Income 22.2% · PAT 100% 81% evidence 12.1/25 ROA 3% · ROE 3.6% · GNPA — 68% evidence 8.0/20 P/BV 0.2× · P/BV÷ROE 0.06 100% evidence 12.7/20 RS sector 3.2% · RS bench 5.5% · 1Y -2.6%9 of 12 weeks ahead 100% evidence
Exact sum: 27.3 + 12.1 + 8 + 12.7 = 60.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Algoquant Fintech LtdALGOQUANT 60.0/100Mixed-positive evidence74% evidence BREAKING OUT 20.0/35 Income 15.7% · PAT 100% 81% evidence 20.3/25 ROA 12% · ROE 28.4% · GNPA — 68% evidence 4.6/20 P/BV 13.51× · P/BV÷ROE 0.48 70% evidence 15.1/20 RS sector 4.5% · RS bench 6.8% · 1Y -7.5%8 of 10 weeks ahead 70% evidence
Exact sum: 20 + 20.3 + 4.6 + 15.1 = 60 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
7CSL Finance LtdCSLFINANCE 59.4/100Mixed-positive evidence90% evidence BASING 20.8/35 Income 19.7% · PAT 14.7% 76% evidence 22.4/25 ROA 9% · ROE 14.9% · GNPA 0.9% 95% evidence 12.0/20 P/BV 0.81× · P/BV÷ROE 0.05 100% evidence 4.2/20 RS sector -14.3% · RS bench -12.5% · 1Y -25.1%1 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 22.4 + 12 + 4.2 = 59.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Master Trust LtdMASTERTR 56.5/100Mixed-positive evidence80% evidence TURNING 13.3/35 Income 7% · PAT 8.1% 81% evidence 18.9/25 ROA 5.6% · ROE 17.3% · GNPA — 68% evidence 15.0/20 P/BV 1.36× · P/BV÷ROE 0.08 70% evidence 9.3/20 RS sector -7% · RS bench -5.7% · 1Y -42%6 of 12 weeks ahead 100% evidence
Exact sum: 13.3 + 18.9 + 15 + 9.3 = 56.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
9STEL Holdings LtdSTEL 54.1/100Mixed-positive evidence80% evidence BREAKING OUT 25.9/35 Income 20.7% · PAT 21.6% 81% evidence 9.0/25 ROA 1.2% · ROE 1.2% · GNPA — 68% evidence 2.9/20 P/BV 0.7× · P/BV÷ROE 0.59 100% evidence 16.3/20 RS sector 20.5% · RS bench 24.4% · 1Y 30.3%10 of 10 weeks ahead 70% evidence
Exact sum: 25.9 + 9 + 2.9 + 16.3 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Mufin Green Finance LtdMUFIN 52.6/100Mixed-positive evidence82% evidence LEADER 24.0/35 Income 27.8% · PAT 100% 86% evidence 11.2/25 ROA 1.3% · ROE 6.7% · GNPA — 72% evidence 3.9/20 P/BV 4.66× · P/BV÷ROE 0.7 70% evidence 13.5/20 RS sector 14.4% · RS bench 17.5% · 1Y 60.5%11 of 12 weeks ahead 100% evidence
Exact sum: 24 + 11.2 + 3.9 + 13.5 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Dolat Algotech LtdDOLATALGO 52.5/100Mixed-positive evidence80% evidence BASING 8.5/35 Income -11.6% · PAT -21.2% 81% evidence 18.1/25 ROA 8.5% · ROE 12.1% · GNPA — 68% evidence 17.1/20 P/BV 1.08× · P/BV÷ROE 0.09 100% evidence 8.8/20 RS sector -0.8% · RS bench -8.7% · 1Y -15.5%0 of 10 weeks ahead 70% evidence
Exact sum: 8.5 + 18.1 + 17.1 + 8.8 = 52.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
12Balmer Lawrie Investment LtdBLIL 51.4/100Mixed-positive evidence86% evidence BASING 14.8/35 Income 8.8% · PAT 4.1% 81% evidence 18.3/25 ROA 7.9% · ROE 12.7% · GNPA — 68% evidence 13.9/20 P/BV 1.06× · P/BV÷ROE 0.08 100% evidence 4.4/20 RS sector -7.3% · RS bench -5.1% · 1Y -26.9%0 of 12 weeks ahead 100% evidence
Exact sum: 14.8 + 18.3 + 13.9 + 4.4 = 51.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
13Bengal & Assam Company LtdBENGALASM 51.3/100Mixed-positive evidence64% evidence 16.7/35 Income 12.1% · PAT 3.4% 62% evidence 12.8/25 ROA — · ROE 8.1% · GNPA — 34% evidence 15.9/20 P/BV 0.67× · P/BV÷ROE 0.08 100% evidence 5.9/20 RS sector -9.4% · RS bench -6.2% · 1Y -26%1 of 8 weeks ahead 70% evidence
Exact sum: 16.7 + 12.8 + 15.9 + 5.9 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14PTC India Financial Services LtdPFS 50.8/100Mixed-positive evidence80% evidence BASING 12.4/35 Income -22.7% · PAT -27.8% 81% evidence 16.8/25 ROA 6.5% · ROE 11% · GNPA — 68% evidence 15.8/20 P/BV 0.57× · P/BV÷ROE 0.05 100% evidence 5.8/20 RS sector -7.1% · RS bench -12% · 1Y -27.9%1 of 10 weeks ahead 70% evidence
Exact sum: 12.4 + 16.8 + 15.8 + 5.8 = 50.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
15Consolidated Finvest & Holdings LtdCONSOFINVT 48.1/100Mixed-negative evidence86% evidence BREAKING OUT 8.1/35 Income -9.1% · PAT -43.9% 81% evidence 13.7/25 ROA 4.3% · ROE 5% · GNPA — 68% evidence 7.1/20 P/BV 0.84× · P/BV÷ROE 0.17 100% evidence 19.2/20 RS sector 36.6% · RS bench 40.7% · 1Y 54.7%11 of 12 weeks ahead 100% evidence
Exact sum: 8.1 + 13.7 + 7.1 + 19.2 = 48.1 · Decision use: Price leads the evidence: RS versus the benchmark is 40.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
16Industrial & Prudential Investment Company LtdINDPRUD 45.6/100Mixed-negative evidence80% evidence ASLEEP 12.5/35 Income -40% · PAT -3.2% 81% evidence 15.6/25 ROA 7.3% · ROE 7.7% · GNPA — 68% evidence 6.3/20 P/BV 1.23× · P/BV÷ROE 0.16 100% evidence 11.2/20 RS sector -3.5% · RS bench 6% · 1Y -1.7%0 of 9 weeks ahead 70% evidence
Exact sum: 12.5 + 15.6 + 6.3 + 11.2 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Finkurve Financial Services LtdFINKURVE 45.3/100Mixed-negative evidence74% evidence BREAKING OUT 21.0/35 Income 59.6% · PAT 62.2% 81% evidence 14.1/25 ROA 2.1% · ROE 9.4% · GNPA — 68% evidence 6.0/20 P/BV 2.95× · P/BV÷ROE 0.31 70% evidence 4.2/20 RS sector -34.3% · RS bench -8.4% · 1Y -29.3%5 of 11 weeks ahead 70% evidence
Exact sum: 21 + 14.1 + 6 + 4.2 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18VLS Finance LtdVLSFINANCE 44.4/100Mixed-negative evidence80% evidence BREAKING OUT 18.1/35 Income -8.4% · PAT 91.7% 81% evidence 7.5/25 ROA 1% · ROE 0.9% · GNPA — 68% evidence 4.9/20 P/BV 0.36× · P/BV÷ROE 0.38 100% evidence 13.9/20 RS sector 9.4% · RS bench -1% · 1Y 9.4%4 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 7.5 + 4.9 + 13.9 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19PTL Enterprises LtdPTL 44.4/100Mixed-negative evidence75% evidence ASLEEP 16.4/35 Income 0% · PAT 13.5% 52% evidence 13.8/25 ROA 3.3% · ROE 5.5% · GNPA — 68% evidence 8.0/20 P/BV 0.6× · P/BV÷ROE 0.11 100% evidence 6.2/20 RS sector -3.9% · RS bench -1.5% · 1Y -3%1 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 13.8 + 8 + 6.2 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20PNB Gilts LtdPNBGILTS 41.4/100Mixed-negative evidence80% evidence ASLEEP 9.1/35 Income -5.3% · PAT -69.7% 81% evidence 9.9/25 ROA 0.7% · ROE 11.1% · GNPA — 68% evidence 15.3/20 P/BV 0.85× · P/BV÷ROE 0.08 100% evidence 7.1/20 RS sector -13.5% · RS bench -1.1% · 1Y -17.8%5 of 10 weeks ahead 70% evidence
Exact sum: 9.1 + 9.9 + 15.3 + 7.1 = 41.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
21NBI Industrial Finance Company LtdNBIFIN 41.1/100Mixed-negative evidence69% evidence TURNING 20.8/35 Income 55.5% · PAT 65.2% 33% evidence 6.1/25 ROA 0.3% · ROE 0.4% · GNPA — 68% evidence 4.6/20 P/BV 0.23× · P/BV÷ROE 0.55 100% evidence 9.6/20 RS sector -5.3% · RS bench -3.4% · 1Y -20%4 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 6.1 + 4.6 + 9.6 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Authum Investment & Infrastructure LtdAIIL 40.9/100Mixed-negative evidence70% evidence FADING 8.6/35 Income -34.6% · PAT -48.8% 62% evidence 15.2/25 ROA — · ROE 12.8% · GNPA — 34% evidence 5.5/20 P/BV 3.14× · P/BV÷ROE 0.24 100% evidence 11.6/20 RS sector 1.4% · RS bench 3.6% · 1Y -11.3%9 of 12 weeks ahead 100% evidence
Exact sum: 8.6 + 15.2 + 5.5 + 11.6 = 40.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Capital India Finance LtdCIFL 39.7/100Thin evidence · provisional57% evidence BASING 17.7/35 Income -1.5% · PAT 100% 52% evidence 8.8/25 ROA 1.7% · ROE -8.6% · GNPA — 68% evidence 9.2/20 P/BV 1.17× · P/BV÷ROE — 40% evidence 4.0/20 RS sector -17.3% · RS bench -28.9% · 1Y -39.2%0 of 10 weeks ahead 70% evidence
Exact sum: 17.7 + 8.8 + 9.2 + 4 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24Grand Oak Canyons Distillery LtdGRANDOAK 38.9/100Mixed-negative evidence71% evidence BREAKING OUT 23.4/35 Income 100% · PAT 100% 54% evidence 4.0/25 ROA 0.1% · ROE 0% · GNPA — 72% evidence 0.7/20 P/BV 2.15× · P/BV÷ROE 215 100% evidence 10.8/20 RS sector 2% · RS bench -5% · 1Y -13.4%9 of 9 weeks ahead 70% evidence
Exact sum: 23.4 + 4 + 0.7 + 10.8 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25The Investment Trust of India LtdTHEINVEST 37.9/100Mixed-negative evidence75% evidence TURNING 11.7/35 Income -22.4% · PAT -13.9% 52% evidence 11.9/25 ROA 2.7% · ROE 4% · GNPA — 68% evidence 8.0/20 P/BV 0.69× · P/BV÷ROE 0.17 100% evidence 6.3/20 RS sector -12.6% · RS bench -10.9% · 1Y -36.9%0 of 12 weeks ahead 100% evidence
Exact sum: 11.7 + 11.9 + 8 + 6.3 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Nalwa Sons Investments LtdNSIL 36.2/100Mixed-negative evidence76% evidence TURNING 18.8/35 Income -20.3% · PAT 37.2% 86% evidence 5.9/25 ROA 0.3% · ROE 0.3% · GNPA — 72% evidence 5.0/20 P/BV 0.19× · P/BV÷ROE 0.56 70% evidence 6.5/20 RS sector -6.7% · RS bench -7.8% · 1Y -21.5%0 of 10 weeks ahead 70% evidence
Exact sum: 18.8 + 5.9 + 5 + 6.5 = 36.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Prime Securities LtdPRIMESECU 34.2/100Adverse evidence86% evidence ASLEEP 8.9/35 Income 14.4% · PAT -80% 81% evidence 13.4/25 ROA 4.6% · ROE 4.1% · GNPA — 68% evidence 3.2/20 P/BV 3.74× · P/BV÷ROE 0.91 100% evidence 8.7/20 RS sector -1.6% · RS bench 0.9% · 1Y 7.1%0 of 12 weeks ahead 100% evidence
Exact sum: 8.9 + 13.4 + 3.2 + 8.7 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Crest Ventures Ltdthis pageCREST 33.0/100Adverse evidence86% evidence ASLEEP 7.1/35 Income -33.2% · PAT -49.3% 81% evidence 12.4/25 ROA 2.5% · ROE 3.8% · GNPA — 68% evidence 8.0/20 P/BV 0.77× · P/BV÷ROE 0.2 100% evidence 5.5/20 RS sector -4.1% · RS bench -1.8% · 1Y -5.7%2 of 12 weeks ahead 100% evidence
Exact sum: 7.1 + 12.4 + 8 + 5.5 = 33 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
29Kiran Vyapar LtdKIRANVYPAR 32.6/100Adverse evidence64% evidence BREAKING OUT 10.2/35 Income 0.9% · PAT -80% 62% evidence 7.3/25 ROA 1.1% · ROE 0.1% · GNPA — 68% evidence 3.4/20 P/BV 0.25× · P/BV÷ROE 5 100% evidence 11.7/20 RS sector — · RS bench 5.2% · 1Y —4 of 7 weeks ahead 25% evidence
Exact sum: 10.2 + 7.3 + 3.4 + 11.7 = 32.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
30Dhunseri Investments LtdDHUNINV 30.8/100Adverse evidence73% evidence BREAKING OUT 15.5/35 Income -12.3% · PAT 17.1% 62% evidence 5.0/25 ROA -0.5% · ROE 0.7% · GNPA — 68% evidence 5.3/20 P/BV 0.22× · P/BV÷ROE 0.33 100% evidence 5.0/20 RS sector -34.7% · RS bench -3.5% · 1Y -29.7%6 of 6 weeks ahead 70% evidence
Exact sum: 15.5 + 5 + 5.3 + 5 = 30.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
31Systematix Corporate Services LtdSYSTMTXC 29.3/100Adverse evidence74% evidence TURNING 9.4/35 Income 14.4% · PAT -80% 81% evidence 12.4/25 ROA 3.2% · ROE 4.6% · GNPA — 68% evidence 4.1/20 P/BV 3.15× · P/BV÷ROE 0.68 70% evidence 3.4/20 RS sector -38.5% · RS bench -20.7% · 1Y -40.2%1 of 10 weeks ahead 70% evidence
Exact sum: 9.4 + 12.4 + 4.1 + 3.4 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
32Oswal Green Tech LtdOSWALGREEN 27.9/100Adverse evidence75% evidence BASING 8.8/35 Income -46.8% · PAT -80% 52% evidence 8.2/25 ROA 1.1% · ROE 1.5% · GNPA — 68% evidence 8.0/20 P/BV 0.22× · P/BV÷ROE 0.15 100% evidence 2.9/20 RS sector -29.4% · RS bench -28.2% · 1Y -50.2%0 of 12 weeks ahead 100% evidence
Exact sum: 8.8 + 8.2 + 8 + 2.9 = 27.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
33Spice Lounge Food Works LtdSPICELOUNG 44.4/100Thin evidence · provisional44% evidence 20.2/35 Income 20.9% · PAT 100% 22% evidence 12.0/25 ROA — · ROE 8.4% · GNPA — 34% evidence 3.3/20 P/BV 15.85× · P/BV÷ROE 1.9 70% evidence 8.9/20 RS sector 0.7% · RS bench -20.9% · 1Y -43%2 of 12 weeks ahead 70% evidence
Exact sum: 20.2 + 12 + 3.3 + 8.9 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Eraaya Lifespaces LtdEBIX 39.5/100Thin evidence · provisional22% evidence 17.5/35 Income — · PAT — 0% evidence 9.3/25 ROA — · ROE -809% · GNPA — 26% evidence 9.2/20 P/BV 6.36× · P/BV÷ROE — 10% evidence 3.5/20 RS sector -34.1% · RS bench -39.5% · 1Y -45.3%8 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 17.5 + 9.3 + 9.2 + 3.5 = 39.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Crest Ventures Ltd's share price today?

Crest Ventures Ltd trades at ₹355, −5.8% over the past year. The company is valued at ₹1,011 Cr. The stock sits at 49% of its 52-week range of ₹310–₹402, −3.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 8 weeks in. — as of 11 September 2026.

What were Crest Ventures Ltd's latest quarterly results?

Crest Ventures Ltd reported total income of ₹30.0 Cr and net profit of ₹11.0 Cr for the Jun 26 quarter. Income fell 52.4% and profit fell 57.7% year on year. Earnings per share were ₹3.99. The net margin was 36.7%, 4.6 pp lower than a year earlier. — as of 11 September 2026.

What is Crest Ventures Ltd's revenue?

Crest Ventures Ltd reported revenue of ₹30.0 Cr in the Jun 26 quarter, −52.4% year on year. For the full FY26 fiscal year, revenue was ₹159 Cr (−22.1%). Over the last 10 years revenue compounded at 12.5% a year. — as of 11 September 2026.

What is Crest Ventures Ltd's profit?

Crest Ventures Ltd earned ₹11.0 Cr of net profit in the Jun 26 quarter, −57.7% year on year. Full-year FY26 profit was ₹48.0 Cr. The net margin ran 36.7% in the latest quarter. — as of 11 September 2026.

What is Crest Ventures Ltd's market cap?

Crest Ventures Ltd's market capitalisation is ₹1,011 Cr at a share price of ₹355. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is Crest Ventures Ltd's P/BV ratio?

Crest Ventures Ltd trades at a P/BV of 0.8×, at the 40th percentile of its own 11-year range, against a long-run median of 0.8×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does Crest Ventures Ltd pay a dividend?

Yes — Crest Ventures Ltd's dividend payout was 6% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is Crest Ventures Ltd overvalued?

On its own history, Crest Ventures Ltd looks mid-range: its P/BV of 0.8× sits at the 40th percentile of its 11-year range (long-run median 0.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is Crest Ventures Ltd growing?

Not right now — Crest Ventures Ltd's latest numbers are shrinking: latest-quarter revenue −52.4% year on year, profit −57.7%, and the net margin −4.6 pp at 36.7%. The 10-year compound rates are 12.5% (revenue) and 2.6% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.

How is Crest Ventures Ltd performing?

Crest Ventures Ltd is in a confirmed uptrend, 8 weeks in. Its latest quarter's income fell 52.4% and profit fell 57.7% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is Crest Ventures Ltd in?

Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −33.2% latest against +36.7% at its 12-quarter best), ROE slipping at 4.0%. The read comes from the last 12 quarters of growth (revenue growth −33.2% latest, profit growth −49.3% latest, eps growth −48.8% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is Crest Ventures Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 8 of stage 2), trading −3.5% versus its 200-day average and at 49% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is Crest Ventures Ltd beating the market?

Not lately — on a trailing-13-week view Crest Ventures Ltd is currently behind the NIFTY 500 (7 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +989% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.

Will Crest Ventures Ltd's share price go up?

This page publishes no price forecast for Crest Ventures Ltd. What it measures instead: the share price is ₹355, the price is in a confirmed uptrend 8 weeks in. Its P/BV of 0.8× sits at the 40th percentile of its own 11-year range. — as of 11 September 2026.

Who owns Crest Ventures Ltd?

Promoters hold 69.8% of Crest Ventures Ltd, foreign institutions 1.7%, domestic institutions null% and the public 27.8% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.

Where is Crest Ventures Ltd in its business cycle?

Crest Ventures Ltd's FY26 net margin was 30.2%, against a 13-year band of 5.5%–99.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 36.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What growth does Crest Ventures Ltd's price assume?

At its price on 13 June 2026, Crest Ventures Ltd was priced for profit growth of about 16.1% a year. Profit itself has compounded 2.6% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.

What could break the Crest Ventures Ltd story?

The sharpest disagreement: the price moved −5.8% in a year while annual EPS moved −47.1% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is Crest Ventures Ltd a stock worth studying right now?

This is not investment advice. The machine read: Crest Ventures Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI